Search
HeartSciences Inc
HSCSAdd to Watchlist
5.200USD
+0.360+7.44%
Close 09-18 16:00（ET）
16.50MMarket Cap
LossP/E TTM
HeartSciences Inc (HSCS) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to HeartSciences Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.000USD+106.61%
HSCS Analyst Recommendation Trends
In the current month, HSCS has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HSCS average Analyst price target in the last month is 10.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
HSCS Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
11
17
6
0
0
34
Edwards Lifesciences Corp
EW
10
14
8
0
0
32
Thermo Fisher Scientific Inc
TMO
10
16
6
0
0
32
Veeva Systems Inc
VEEV
7
15
8
1
0
31
Danaher Corp
DHR
11
13
4
0
0
28
Waters Corp
WAT
8
10
9
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Illumina Inc
ILMN
5
7
7
2
1
22
Resmed Inc
RMD
2
7
10
1
1
21
Financial Forecasting
Based on analysts' estimates, HSCS EPS is projected to reach -0.740 in FY2027Q2, following reported EPS of -0.865 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
-0.85
-0.73
-0.72
-0.74
-0.75
Actual
-0.63
-0.88
-0.86
--
--
Surprise
+26.14%
-19.94%
-19.26%
--
--
FAQs
What is HeartSciences Inc's expected revenue for the next quarter?
HeartSciences Inc's expected revenue is 50.00K.
What is HeartSciences Inc's price target?
Analysts forecast that HeartSciences Inc's price target is USD 10.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 8.00.
How have HeartSciences IncHSCS's recent earnings per share performed?
The market expectation was USD -0.86, while HeartSciences IncHSCS's earnings per share (EPS) for the previous quarter was USD -0.88. EPS for the next quarter is expected at USD -0.74.
What is the analyst rating for HeartSciences Inc?
Based on the ratings of HeartSciences Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.